Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company's exclusive sales and marketing partner for AmnioWrap2®</p ...

Johnson & Johnson (NYSE:JNJ) lowered its full-year earnings outlook on Tuesday despite posting better-than-expected ...

BTIG analyst Ryan Zimmerman raised the firm’s price target on Globus Medical to $78 from $77 and keeps a Buy rating on the ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.

V2X, Inc., , a leading provider of global mission solutions, will report third quarter 2024 financial results on Monday, November 4, 2024, after market close. Senior management will conduct a ...

EDITEDtm, the leading global retail intelligence platform, today announced Mike MacKeen as the company's new Chief Financial Officer. MacKeen is a seasoned executive with deep operational and ...

Johnson & Johnson shares are up 3.1% in 2024, compared with the S&P 500 index's SPX gain of 22.9%. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is ...

AcuityMD, a leading technology provider to the medical technology (MedTech) industry, today announced the launch of AcuityMD ...

Neurotech Reports announced that executives from several emerging neurotechnology startups will present for the first time at ...

Johnson & Johnson's third-quarter performance exceeded expectations, with adjusted EPS of $2.42 against an expected $2.19.

York-based medical testing kit firm Abingdon Health is boosting its US presence by opening a commercial office and laboratory in the US.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.